Accuray receives ce mark for a new helical radiation delivery system, accuray helix™

Developed for india and other countries where patient access to care with radiotherapy is challenged and where versatility and ease of use are a high priority drives the next phase of company's strategic plan to expand its portfolio of helical radiation therapy delivery systems madison, wis. , aug. 27, 2024 /prnewswire/ -- accuray incorporated (nasdaq: aray) announced today the company has received ce mark for accuray helix™, a ct-guided helical radiotherapy system designed to provide high-performance and high-throughput.
ARAY Ratings Summary
ARAY Quant Ranking